A biepitope, adjuvant-free, self-assembled influenza nanovaccine provides cross-protection against H3N2 and H1N1 viruses in mice

Currently, the incorporation of multiple epitopes into vaccines is more desirable than the incorporation of a single antigen for universal influenza vaccine development. However, epitopes induce poor immune responses. Although the use of adjuvants can overcome this obstacle, it may raise new problem...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Yongbo, Zhang, YaXin, Chen, Jie, Jin, Shenghui, Shan, Yaming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tsinghua University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325945/
https://www.ncbi.nlm.nih.gov/pubmed/35911479
http://dx.doi.org/10.1007/s12274-022-4482-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325945/
https://www.ncbi.nlm.nih.gov/pubmed/35911479
http://dx.doi.org/10.1007/s12274-022-4482-4

Ejemplares similares